570 — China Traditional Chinese Medicine Holdings Co Share Price
0.000.00%
Last trade - 00:00- HK$21.75bn
- HK$26.12bn
- CNY18.12bn
- 65
- 61
- 88
- 87
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 10.08 | ||
| PEG Ratio (f) | 0.38 | ||
| EPS Growth (f) | 35.86% | ||
| Dividend Yield (f) | 4.49% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.95 | ||
| Price to Tang. Book | 1.65 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.11 | ||
| EV to EBITDA | 9.54 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.15% | ||
| Return on Equity | 6.22% | ||
| Operating Margin | 7.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 14,320.95 | 14,806.17 | 19,052.8 | 14,304.24 | 18,121.86 | 24,125.72 | 29,652.5 | 9.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.33 | +7.89 | +13.29 | -52.98 | +39.28 | +49.05 | +15.61 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.
Directors
- Xian Wu CHM (60)
- Xueren Cheng PRE (58)
- Xiaochun Wang NVC (53)
- Lixin Shen CFO (54)
- Wenming Yang VPR (57)
- Dongji Zhao VPR (53)
- Zhangxin Huang VPR (53)
- Qingshan Lan VPR (56)
- Qingsheng Zhang VPR (60)
- Suet Lun Leung SEC
- Kaipin Kui NED (35)
- Ru Li NED (41)
- Kan Wang NED (36)
- Binghua Yang NED (40)
- Shanhua Yang NED (54)
- Weidong Li NID (53)
- Ling Qin NID (62)
- Rong Xie NID (68)
- Tze Shan Yu NID (64)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 23rd, 1992
- Public Since
- April 7th, 1993
- No. of Employees
- 17,303
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 5,035,801,000
- Address
- Room 1601, Emperor Group Centre
- Web
- https://www.china-tcm.com.cn/
- Phone
- +852 null28543393
- Contact
- Tony Guan
- Auditors
- Ernst & Young
Upcoming Events for 570
Similar to 570
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the China Traditional Chinese Medicine Holdings Co share price?
As of Today at 19:23 UTC, shares in China Traditional Chinese Medicine Holdings Co are trading at HK$4.32. This share price information is delayed by 15 minutes.
How has the China Traditional Chinese Medicine Holdings Co share price performed this year?
Shares in China Traditional Chinese Medicine Holdings Co last closed at HK$4.32 and the price had moved by +4.35% over the past 365 days. In terms of relative price strength the China Traditional Chinese Medicine Holdings Co share price has outperformed the FTSE Developed Asia Pacific Index by +8.92% over the past year.
What are the analyst and broker recommendations for China Traditional Chinese Medicine Holdings Co?
The overall consensus recommendation for China Traditional Chinese Medicine Holdings Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the China Traditional Chinese Medicine Holdings Co dividend yield?
China Traditional Chinese Medicine Holdings Co does not currently pay a dividend.
Does China Traditional Chinese Medicine Holdings Co pay a dividend?
China Traditional Chinese Medicine Holdings Co does not currently pay a dividend.
When does China Traditional Chinese Medicine Holdings Co next pay dividends?
China Traditional Chinese Medicine Holdings Co does not currently pay a dividend.
How do I buy China Traditional Chinese Medicine Holdings Co shares?
To buy shares in China Traditional Chinese Medicine Holdings Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of China Traditional Chinese Medicine Holdings Co?
As of the previous close price of HK$4.32, shares in China Traditional Chinese Medicine Holdings Co had a market capitalisation of HK$21.75bn.
Where are China Traditional Chinese Medicine Holdings Co shares listed?
Here are the trading details for China Traditional Chinese Medicine Holdings Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 570
What kind of share is China Traditional Chinese Medicine Holdings Co?
Based on an overall assessment of its quality, value and momentum China Traditional Chinese Medicine Holdings Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a China Traditional Chinese Medicine Holdings Co share price forecast for 2024?
The analyst consensus target price for shares in China Traditional Chinese Medicine Holdings Co is HK$4.40. That is 1.93% above the last closing price of HK$4.32.
Analysts covering China Traditional Chinese Medicine Holdings Co currently have a consensus Earnings Per Share (EPS) forecast of CNY0.38 for the next financial year.
What is the trend in the China Traditional Chinese Medicine Holdings Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Traditional Chinese Medicine Holdings Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +15.48%.
As of the last closing price of HK$4.32, shares in China Traditional Chinese Medicine Holdings Co were trading +19.17% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the China Traditional Chinese Medicine Holdings Co PE Ratio?
The China Traditional Chinese Medicine Holdings Co PE ratio based on its reported earnings over the past 12 months is 10.08. The shares last closed at HK$4.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of China Traditional Chinese Medicine Holdings Co?
China Traditional Chinese Medicine Holdings Co's management team is headed by:
- Xian Wu - CHM
- Xueren Cheng - PRE
- Xiaochun Wang - NVC
- Lixin Shen - CFO
- Wenming Yang - VPR
- Dongji Zhao - VPR
- Zhangxin Huang - VPR
- Qingshan Lan - VPR
- Qingsheng Zhang - VPR
- Suet Lun Leung - SEC
- Kaipin Kui - NED
- Ru Li - NED
- Kan Wang - NED
- Binghua Yang - NED
- Shanhua Yang - NED
- Weidong Li - NID
- Ling Qin - NID
- Rong Xie - NID
- Tze Shan Yu - NID